← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Neovaxsyn, Inc.
Ames, IA
$4,251,873
Total funding
7
Grants
Funding over time
peak $2.3M · FY2019–24$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,251,873 · 7
By mechanism
N44$2,000,000 · 1
N43$1,199,999 · 4
R43$597,312 · 1
R21$454,562 · 1
Investigators at Neovaxsyn, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Nanovaccine for Eliciting bnAbs Against HIV-1$2,000,000
N44 · FY2024 · AI
Development of a Next-Generation Immunoprevention Platform Against HIV-1$300,000
N43 · FY2024 · AI
Induction of bnAbs against HIV-1 gp41.$300,000
R43 · FY2023 · MH
Nanovaccine for eliciting 10E8-like bnAbs against HIV-1$300,000
N43 · FY2021 · AI
Preclinical evaluation of HIV-1 envelope immunogens in humanized mice$300,000
N43 · FY2022 · AI
A Nanovaccine for Eliciting Broadly Neutralizing Antibodies Against HIV-1$299,999
N43 · FY2020 · AI
Induction of bnAbs against HIV-1 gp41.$297,312
R43 · FY2022 · MH
Evaluation of a Novel Antigen-Enhanced, Anti-Idiotypic Antibody Vaccine Strategy$250,449
R21 · FY2020 · AI
Evaluation of a Novel Antigen-Enhanced, Anti-Idiotypic Antibody Vaccine Strategy$204,113
R21 · FY2019 · AI